Want to join the conversation?
$STZ expects diluted EPS accretion from the Meiomi acquisition to be around $0.07-0.08 in FY16 versus the previous $0.03-0.04 projection. On a comparable basis, the Ballast Point acquisition is expected to be neutral to diluted EPS for FY16 and $0.05-0.06 accretive for FY17.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.